ESR1 and invasive breast carcinoma: BrCa is a heterogeneous disease with diverse pathogenesis, which is mainly classified into four molecular subtypes, characterized by the expression of Estrogen Receptor (ERα), Progesterone receptor (PR) and the Epidermal Growth Factor Receptor (EGFR) family member Her2 [2].